Hologic, Inc. (HOLX)

NASDAQ: HOLX · Real-Time Price · USD
81.72
-0.28 (-0.34%)
Sep 18, 2024, 4:00 PM EDT - Market closed
-0.34%
Market Cap 18.98B
Revenue (ttm) 3.99B
Net Income (ttm) 701.50M
Shares Out 232.27M
EPS (ttm) 2.92
PE Ratio 28.03
Forward PE 19.07
Dividend n/a
Ex-Dividend Date n/a
Volume 999,593
Open 81.39
Previous Close 82.00
Day's Range 81.18 - 82.18
52-Week Range 64.02 - 84.67
Beta 0.98
Analysts Buy
Price Target 87.60 (+7.2%)
Earnings Date Nov 7, 2024

About HOLX

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis ass... [Read more]

Sector Healthcare
IPO Date Jun 21, 1990
Employees 6,990
Stock Exchange NASDAQ
Ticker Symbol HOLX
Full Company Profile

Financial Performance

In 2023, Hologic's revenue was $4.03 billion, a decrease of -17.12% compared to the previous year's $4.86 billion. Earnings were $456.00 million, a decrease of -64.98%.

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for HOLX stock is "Buy." The 12-month stock price forecast is $87.6, which is an increase of 7.20% from the latest price.

Price Target
$87.6
(7.20% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Hologic to Webcast Presentation at the Morgan Stanley 22nd Annual Global Healthcare Conference

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #holx--Hologic to Webcast Presentation at the Morgan Stanley 22nd Annual Global Healthcare Conference.

20 days ago - Business Wire

Hologic CEO on earnings beat: our Covid work has 'turbocharged' diagnostics business

Stephen MacMillan, Hologic CEO, joins 'Money Movers' to discuss the company's earnings, how the company is encouraging women to get health screenings, and more.

7 weeks ago - CNBC Television

Hologic Analysts Boost Their Forecasts After Q3 Results

Hologic, Inc. HOLX reported upbeat earnings for its third quarter, but issued soft guidance on Monday.

7 weeks ago - Benzinga

Hologic, Inc. (HOLX) Q3 2024 Earnings Call Transcript

Hologic, Inc. (NASDAQ:HOLX) Q3 2024 Earnings Conference Call July 29, 2024 4:30 AM ET Company Participants Ryan Simon - VP, IR Stephen MacMillan - Chairman, President & CEO Essex Mitchell - COO Karle...

7 weeks ago - Seeking Alpha

Hologic quarterly profit rises on strong demand for its women's health products

Medical technology company Hologic reported a higher third-quarter profit on Monday, driven by strong demand for its diagnostics and breast health products, but forecast revenue for the current quarte...

7 weeks ago - Reuters

Hologic Announces Financial Results for Third Quarter of Fiscal 2024

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic Announces Financial Results for Third Quarter of Fiscal 2024.

7 weeks ago - Business Wire

Hologic Completes Acquisition of Endomagnetics Ltd

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #breastcancersurgery--Hologic Completes Acquisition of Endomagnetics Ltd.

7 weeks ago - Business Wire

72 Million American Women Have Skipped or Delayed Vital Screenings

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #HGWHI--72 Million American Women Have Skipped or Delayed Vital Screenings.

2 months ago - Business Wire

Hologic to Announce Financial Results for the Third Quarter of Fiscal 2024 on Monday, July 29, 2024

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic to Announce Financial Results for the Third Quarter of Fiscal 2024 on Monday, July 29, 2024.

2 months ago - Business Wire

Women's Health-Focused Hologic Has Significant Capacity For Expansion Via M&A, Bullish Analyst Says

Stephens initiated coverage on Hologic Inc HOLX, citing it as a major player in women's health, known for its consistent revenue growth, strong free cash flow, and attractive profit margins, is well-p...

2 months ago - Benzinga

Hologic CEO breaks down AI involvement in healthcare

Steve MacMillan, Hologic CEO, joins 'Squawk on the Street' to discuss how Hologic is installing AI into its products, how the company innovates on its products, and what specific problems are being so...

3 months ago - CNBC Television

FDA classifies recall of Hologic's implants for soft tissue as 'most serious'

The U.S. Food and Drug Administration on Wednesday classified a recall of Hologic's devices that are implanted in soft tissue such as breast tissue as "most serious".

4 months ago - Reuters

Hologic to Webcast Presentations at Upcoming Investor Conferences

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #holx--Hologic to Webcast Presentations at Upcoming Investor Conferences.

4 months ago - Business Wire

Hologic: Women's Health Play Looks Healthier Itself

Hologic's women's health business benefited from the pandemic but is now facing headwinds that will end in 2024. The company has a strong balance sheet, solid track record, and reasonable valuation, m...

4 months ago - Seeking Alpha

Hologic, Inc. (HOLX) Q2 2024 Earnings Call Transcript

Call Start: 16:30 January 1, 0000 5:24 PM ET Hologic, Inc. (NASDAQ:HOLX) Q2 2024 Earnings Conference Call May 2, 2024 16:30 ET Company Participants Ryan Simon - Vice President, Investor Relations Ste...

4 months ago - Seeking Alpha

Hologic Announces Financial Results for Second Quarter of Fiscal 2024

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic Announces Financial Results for the Second Quarter of Fiscal 2024.

4 months ago - Business Wire

Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #acquisition--Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company.

5 months ago - Business Wire

Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer and Hologic, Inc. (Nasdaq: HOLX) today announced a first-of-its-kind collaboration to deliver a coordinated solution for contrast-enhanced mammography (CEM). The...

5 months ago - Business Wire

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024.

6 months ago - Business Wire

Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #JNCCN--Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors .

7 months ago - Business Wire

FDA warns of potential risk of complications with use of Hologic's devices

The U.S. Food and Drug Administration on Tuesday warned patients and healthcare providers about the potential risk of serious complications arising from the use of Hologic's devices that are implanted...

7 months ago - Reuters

Hologic to Unveil Groundbreaking AI Research at ECR 2024

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #AI--Hologic to Unveil Groundbreaking AI Research at ECR 2024.

7 months ago - Business Wire

Hologic: Prospects For Growth As Headwinds Disappear

Hologic aims to elevate women's health globally, with diagnostics making up nearly half of sales. The company experienced a boom in COVID diagnostics sales in 2020 and 2021, creating headwinds thereaf...

7 months ago - Seeking Alpha

Hologic CEO on Q1 earnings, AI in health care

Steve MacMillan, Hologic CE, joins 'Money Movers' to discuss the company's new AI cervical screening system, Hologic's quarterly earnings results, and more.

8 months ago - CNBC Television

Hologic, Inc. (HOLX) Q1 2024 Results - Earnings Call Transcript

Hologic, Inc. (HOLX) Q1 2024 Results - Earnings Call Transcript

8 months ago - Seeking Alpha